Dear Doctor Letter (Rote-Hand-Brief) on methotrexate: new measures to avoid potentially fatal dosage errors with methotrexate in autoimmune diseases
2019.11.25
Active substance: methotrexate
Marketing authorisation holders of medicinal products containing methotrexate would like to inform you in agreement with the European Medicines Agency (EMA) and the Federal Institute for Drugs and Medical Devices (BfArM) about new measures to avoid potentially fatal dosage errors with methotrexate in autoimmune diseases.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN